Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives (2022)
- Authors:
- USP affiliated authors: MOREIRA, NATALIA CHERMONT DOS SANTOS - FMRP ; LIMA, JÉSSICA ELLEN BARBOSA DE FREITAS - FMRP ; CARVALHO, IVONE - FCFRP ; HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; MARCHIORI, MARCELO FIORI - FCFRP
- Unidades: FMRP; FCFRP; FFCLRP
- DOI: 10.3233/ADR-210061
- Subjects: DOENÇA DE ALZHEIMER; NEUROLOGIA
- Keywords: Acetylcholinesterase; Butyrylcholinesterase; Neurodegenerative diseases; Neuroprotection; PI3K/AKT pathway
- Language: Inglês
- Imprenta:
- Publisher place: Thousand Oaks
- Date published: 2022
- Source:
- Título: Journal of Alzheimer's Disease Reports
- ISSN: 2542-4823
- Volume/Número/Paginação/Ano: v. 6, n. 1, p. 177-193, 2022
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MOREIRA, Natália Chermont dos Santos et al. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives. Journal of Alzheimer's Disease Reports, v. 6, n. 1, p. 177-193, 2022Tradução . . Disponível em: https://doi.org/10.3233/ADR-210061. Acesso em: 11 maio 2026. -
APA
Moreira, N. C. dos S., Lima, J. E. B. de F., Marchiori, M. F., Carvalho, I., & Sakamoto-Hojo, E. T. (2022). Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives. Journal of Alzheimer's Disease Reports, 6( 1), 177-193. doi:10.3233/ADR-210061 -
NLM
Moreira NC dos S, Lima JEB de F, Marchiori MF, Carvalho I, Sakamoto-Hojo ET. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives [Internet]. Journal of Alzheimer's Disease Reports. 2022 ; 6( 1): 177-193.[citado 2026 maio 11 ] Available from: https://doi.org/10.3233/ADR-210061 -
Vancouver
Moreira NC dos S, Lima JEB de F, Marchiori MF, Carvalho I, Sakamoto-Hojo ET. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives [Internet]. Journal of Alzheimer's Disease Reports. 2022 ; 6( 1): 177-193.[citado 2026 maio 11 ] Available from: https://doi.org/10.3233/ADR-210061 - Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway
- Mechanisms underlying the pathophysiology of type 2 diabetes: from risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia
- Oxidative stress, DNA damage, and transcriptional expression of DNA repair and stress response genes in diabetes mellitus
- Novel AChE and ROCK dual inhibitor designed for Alzheimer's disease therapy promotes neurodifferentiation and neuritogenesis in SHSY5Y cells
- Neuroprotective effect of acetylcholinesterase inhibitors in response to oxidative stress in neuronal SH-SY5Y cell line
- Brain organoids as a neuronal model applied in neuroscience and neurodegenerative diseases
- Acetylcholinesterase inhibitory activity, anti-inflammatory, and neuroprotective potential of Hippeastrum psittacinum (Ker Gawl.) herb (Amaryllidaceae)
- Novel dual AChE and ROCK2 inhibitor induces neurogenesis via PTEN/AKT pathway in Alzheimer’s disease model
- Insights into anti-trypanosomal agents based on synthetic glycoconjugates
- Estudo do potencial efeito neuroprotetor de inibidores de acetilcolinesterase em resposta ao estresse oxidativo induzido pelo peróxido de hidrogênio em linhagem neuronal SH-SY5Y
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003275559.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
